Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
--------
Question: Not applicable. It’s understandable that costs wouldn’t be discussed at this early stage of research. Adequate explanation of results observed in study participants at different dosing levels. More importantly, the story simply explained: “Since it’s not completely clear what reductions in brain plaques mean for Alzheimer’s patients, the researchers are unable to say whether treatment with gantenerumab will bring improvement to patients with Alzheimer’s. They are currently involved in a new study that they hope will answer that question.” Better than its HealthDay competition in that WebMD actually told us how many people experienced harms in the study. The story allowed a Roche senior VP to say the results “went beyond our expectations” but countered that with “What is not entirely known is if these plaques cause Alzheimer’s…Therefore, it’s not known if reducing the amount of them will slow or stop the disease.” No disease mongering at play here. The story added an important independent perspective and identified the study co-author as being a senior VP of the drug company making the drug. We preferred how HealthDay explained:  “There are approximately one dozen therapies, including vaccines, that are currently in the pipeline….none are ready for prime time.” The story ends with an appropriate send-off:  “We need more studies to know if it is safe or effective.”  The early, experimental nature of the research is clear. The HealthDay competitor did a better job of explaining where this study fits in the history of research into beta-amyloid. There was clear evidence of independent reporting.

Answer: Drug May Reduce Plaque in Brains of Alzheimer’s Patients


Question: Maria Andrade of Cape Verde, Robert Mwanga of Uganda and American Jan Low, who all are from the Lima, Peru-based International Potato Center, and American Howarth Bouis of the international research group HarvestPlus were honored in a ceremony at the U.S. State Department. Kenneth M. Quinn, president of the World Food Prize Foundation, called their work “a breakthrough achievement in developing and implementing biofortification.”  He defined biofortification as “the process of breeding critical vitamins and micronutrients into staple crops, thereby dramatically reducing hidden hunger and improving health for millions and millions of people.”  The honorees’ work has focused on the orange-fleshed sweet potato, an important source of vitamin A, especially in sub-Saharan Africa. Vitamin A deficiency, especially there and in Asia, is a cause of blindness and premature death, according to the International Potato Center, an agriculture research center based in Lima, Peru. “The impact of the work of all four winners will be felt around the globe but particularly in sub-Saharan Africa,” said Gayle Smith, head of the U.S. Agency for International Development. The prize is awarded annually by the World Food Prize Foundation for food and agriculture innovation. The scientists will share the $250,000 prize equally and it will be awarded at a ceremony during World Food Prize week in Des Moines, Iowa, in October, when the prize will celebrate its 30th anniversary. Past recipients include John Kufuour, a former president of Ghana; former U.S. Senators Bob Dole and George McGovern; and Grameen Bank founder and Nobel laureate Dr. Muhammad Yunus of Bangladesh.

Answer: Sweet potato experts win World Food Prize.


Question: The purpose of the fund is to assist developing countries with weak health systems in addressing the crisis as well as to tackle the long-term consequences. The United Nations could make a formal announcement this week, the ministry said. Norway, which suggested the fund, has not committed how much money it would put into the initiative, similar to a 2014 United Nations Ebola Response Fund. “We want to make sure that the efforts are as unified as possible and as early as possible so that we can answer up to the demands that countries will have, especially the poorest countries,” Foreign Minister Ine Eriksen Soereide told Reuters. Almost 340,000 people have been infected by the novel coronavirus across the world and more than 14,500 have died, with deaths in Italy surpassing the toll in China, where the outbreak began, according to a Reuters tally. In Africa, Angola, Eritrea and Uganda have confirmed their first cases, while Mauritius recorded its first death as the virus spreads across the continent despite efforts by governments to hold it back. In the Middle East, the first two cases of coronavirus were confirmed in the densely populated Gaza Strip on Sunday. U.N. Secretary-General Antonio Guterres on Thursday called on wealthy countries to not just think about their citizens but help less-prepared nations tackle the crisis. “A wealthy country must not be convinced that it has only to deal with its own citizens. It’s in the interests of a wealthy country to contribute to a global response because the crisis can come from wherever, at any moment,” he told reporters.

Answer:
U.N. to create global coronavirus fund, Norway says.